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Abstract 
 
Background: Benzodiazepines and z-drugs are used to treat complaints like 
insomnia, anxiety and pain. These drugs are recommended for short-term use only, 
but many studies report long-term use, particularly in older people.  
 
Objective: To identify and synthesise qualitative studies exploring patients’ 
experiences and perceptions of receiving benzodiazepines and z-drugs, and through 
this identify factors which perpetuate use of these drugs, and strategies for achieving 
safer prescribing.   
 
Methods: A systematic search of six databases for qualitative studies exploring 
patients’ experiences and perceptions of primary care benzodiazepine and z-drug 
prescribing published between January 2000 and April 2014 in a European language, 
and conducted in Europe, the United States, Australia or New Zealand. Reference 
lists of included papers were also searched. Study quality was assessed using the 
Critical Appraisal Skills Programme qualitative checklist. Findings were synthesised 
using thematic synthesis. 
 
Results: Nine papers were included and seven analytical themes were identified 
relating to patients’ experiences and perceptions and, within that, strategies for safer 
prescribing of benzodiazepines and z-drugs: 1) patients’ negative perceptions of 
insomnia and its impact, 2) failed self-care strategies, 3) triggers to medical help-
seeking, 4) attitudes towards treatment options and service provision, 5) varying 
patterns of use, 6) withdrawal, 7) reasons for initial or ongoing use.  
 
Conclusions: Inappropriate use and prescribing of benzodiazepines and z-drugs is 
perpetuated by psychological dependence, absence of support and patients’ 
denial/lack of knowledge of side-effects. Education strategies, increased availability 
of alternatives, and targeted extended dialogue with patients could support safer 
prescribing. 
 
Key Points 
 Long-term use of benzodiazepines and z-drugs can have adverse 
consequences, but research reports long-term use, particularly in older 
people 
 4 
 We identified seven themes from published qualitative research which add to 
our understanding of patients’ experiences and perceptions of seeking and 
using these drugs, and factors perpetuating their use  
 Safer prescribing could be supported through education strategies for patients 
and healthcare professionals, increased availability of alternatives, and 
targeted extended dialogue between patients and healthcare professionals 
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1 Introduction 
Benzodiazepines (e.g. diazepam, temazepam, lorazepam [BZDs]) and z-drugs (e.g. 
zopiclone, zolpidem, zaleplon) are commonly prescribed for insomnia, and are also 
used to manage anxiety and pain. Guidelines suggest that if these drugs are 
prescribed, they should only be used short-term [1-4]. However, research indicates 
that they are often prescribed long-term [5, 6]. This is concerning, as BZDs and z-
drugs are known to have limited long-term therapeutic benefits, and also have 
adverse consequences for patients, such as dependency, daytime sedation, 
cognitive impairment and increased rates of falls and accidents [5]. Despite the risks, 
use of these drugs is particularly common in older people [7]. In a previous study, we 
conducted a systematic review and meta-synthesis which identified influences on 
general practitioner (GP) prescribing of these drugs. Here, findings suggested that 
GPs were more tolerant of long-term use in older compared with younger patients [8].  
 
In this study, we present a systematic review and meta-synthesis of literature from 
the perspective of patients, aiming to explore their experiences and perceptions of 
receiving BZDs and z-drugs in primary care. We sought to identify factors which 
perpetuate the use of these drugs and to make recommendations for supporting 
safe, effective and patient-centred approaches to prescribing.  
 
2 Methods 
We conducted a systematic search for qualitative studies exploring patients’ 
experiences and perceptions of primary care benzodiazepine and z-drug prescribing. 
The search encompassed six databases: MEDLINE, CINAHL, Social Science 
Citation Index, Science Citation Index, PsycINFO, and AMED. A search strategy was 
initially developed for MEDLINE (Supplementary Table 1), and subsequently adapted 
for the remaining databases. All databases were searched by May 2014. 
 
2.1 Inclusion and Exclusion Criteria 
Studies were included if they: involved qualitative analysis of patient experiences of 
receiving BZDs and z-drugs; were published between January 2000 and April 2014 
to ensure relevance to current practice and the historical context of benzodiazepine 
prescribing; were published in a European language; and were conducted in Europe, 
the United States, Australia or New Zealand.  
 
Studies which were not relevant to the focus of the review or were published outside 
these dates, languages and settings were excluded.  
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The initial search identified a total of 3975 papers. After removing duplicates, NS, CS 
and SYC examined either the title, abstract or full paper (where relevance was 
unclear), and identified 7 papers for inclusion. Following a review of the reference 
lists of included papers and correspondence with the author of one of the included 
papers, two additional papers were identified for inclusion (Figure 1). One of these [9] 
was published after the cut-off date for the original search, but was included as it 
contained relevant data and had been accepted for publication in March 2014.  
 
[Figure 1 Search Results here] 
 
2.2 Data extraction and quality assessment 
Three researchers (CS, RP and SYC) independently extracted data from included 
studies on their aims, sample, method(s) of data collection and analysis, and 
theoretical perspective using a data extraction form created for the study; and 
assessed them using the Critical Appraisal Skills Programme (CASP) qualitative 
checklist [10]. A fourth researcher (NS) independently assessed all of the included 
papers for comparison. Agreement on ratings was reached after discussion as a 
group. 
 
2.3 Data Synthesis 
Data were analysed in NVivo 10 using thematic synthesis [11]. Initially, two 
researchers (CS and SYC) independently coded the ‘results’ sections of the included 
papers line-by-line, allocating codes based on the meaning of each line using an 
inductive approach. This resulted in the data being coded into 26 themes as free 
nodes in NVivo. We then met to discuss this initial coding, and make amendments 
required to ensure consistent coding into all of these themes across all papers. Next, 
as a group (CS, SYC, NS) we organised the codes into higher-level descriptive 
themes that encapsulated the meaning of groups of our initial codes. Finally, we 
considered these themes in relation to our research question – developing our final 
analytical themes (see below, and see Supplementary Table 1 for further details of 
this process). 
 
 
3 Results 
3.1 Data Extraction 
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The nine included studies were published between 2003 and 2015 and were from 
four countries (Australia, Belgium, UK, USA) [12, 13, 9, 14-19]. Participants in these 
studies were mainly older adults that were frequent users of BZDs. Most studies 
contained a mixture of men and women, but there were more female participants 
overall. Studies were based on both semi-structured interviews and focus groups. 
Some studies employed mixed-methods, in which case only the qualitative 
component was included in the meta-synthesis presented here. Various methods of 
analysis were employed in the studies including content analysis, thematic analysis 
and the constant comparative method (Table 1).  
 
[Table 1 Description of studies included in the review here] 
 
Whilst all of the included studies contained data about patients’ experiences and 
perceptions of receiving BZDs and z-drugs, there was some variation in the primary 
focus of the papers. For three studies [12, 16, 17] the primary focus was on 
insomnia, whilst for others the primary focus was on broader aspects of the use of 
these drugs and (in some cases) implications for service development. 
 
3.2 Quality Assessment 
The CASP criteria for qualitative research were applied to each paper. This checklist 
supports critical appraisal of research by asking reviewers to score papers against 
questions about ten domains that should be considered in qualitative research. 
Papers receive ratings of either ‘zero’, or ‘one’ in each domain. Papers only received 
a score of zero if the domain had not been addressed at all in the paper. The scores 
received ranged from eight to ten, indicating high quality. No studies were excluded 
on the basis of the quality assessment (Supplementary Table 2). 
 
3.3 Data Synthesis 
After initial coding and development of descriptive themes, we developed seven 
analytical themes as detailed below (see Supplementary Table 3 for more on this). 
These focused on patients’ experiences and perceptions of receiving BZDs and z-
drugs. Within our data analysis we focused on insights gained from the data on 
strategies for encouraging safer prescribing of BZDs and z-drugs. We organised the 
themes chronologically into a model representing a patient’s journey from identifying 
that they have a health problem, through to using BZDs or z-drugs, withdrawing from 
them, or (in some cases) continuing to use these medications contrary to medical 
guidelines [Figure 2].   
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[Figure 2 Model of themes here] 
 
3.3.1 Patients’ negative perceptions of insomnia and its impact 
Several studies, specifically those that focused on the management of insomnia, 
discussed the start of the patient journey – in this case, patients perceiving that they 
had a problem with sleep. Although other studies included patients using BZDs or z-
drugs in relation to other conditions (e.g. anxiety), we were unable to create 
equivalent themes for these conditions from the data available. Three studies [12, 17, 
16] gave insight into patients’ perceptions of insomnia, its causes and consequences, 
and the relationship between this condition and medical help-seeking.  
 
Patients perceived insomnia as involving difficulty falling asleep or waking after sleep 
onset: 
 
“They described difficulty with falling asleep…comments included…”I toss 
and turn”, “It takes me four or five hours to fall asleep”…waking after sleep 
onset was also common” [12] 
 
“Many reported being able to get to sleep, but then waking in the early hours 
of the morning and being unable to return to sleep” [16]  
 
The condition was attributed to a variety of causes including depression, shift work, 
post-traumatic stress disorder and lifestyle factors.  
 
The studies pointed to the relationship between insomnia and other health 
conditions. This relationship was two-way – firstly, insomnia was cited as causing 
other health problems:  
 
“‘I said to my doctor recently, “when I die…I don’t want breast cancer on my 
death certificate, I don’t want emphysema, I want insomnia because I am sure 
that’s at the root of all my problems’” [17] 
 
“‘I think a lot of it is because I’m so tired, that is what causes the depression’” 
[17] 
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Secondly, insomnia was cited as being caused by other health problems. For 
example, arthritic pain and heart failure were cited as causing/precipitating insomnia; 
and patients viewed insomnia as being perpetuated by other comorbid physical and 
mental health conditions such as back pain, nocturia and anxiety. In one paper, 
adverse reactions to medication and the position of devices such as pacemakers 
were also said to perpetuate insomnia [12].  
 
Insomnia was seen as having a deep and wide-reaching negative impact on patients’ 
quality of life in both health and psychosocial areas, including patients being unable 
to enjoy activities because they were too tired:  
 
“‘I was having marriage problems because of this thing of not sleeping’” [17] 
 
“Insomnia often led to inability to do or enjoy previously enjoyable activities, 
such as concerts, travelling, shopping or visiting with grandchildren” [12] 
 
“They were plagued with memory problems, stating that their ‘minds were not 
what they used to be’ and perceived that their memory problems are worse 
after ‘a bad night’” [12]  
 
The perceived severity of this negative impact of insomnia was one factor which led 
patients to seek medical help.  
 
3.3.2 Failed self-care strategies  
Studies showed that, prior to seeking help from a healthcare professional, patients 
with sleep problems and with difficulties coping with ‘life stressors’ [19] had tried to 
cope with their health problem in other ways including attempting to distract 
themselves, lifestyle changes, and using alternatives to prescription drugs: 
 
“Night time routines included playing “mind games” to distract themselves 
from insomnia, worries and fears. The most common was going to bed late 
and watching television until falling asleep…Others used distraction through 
music, reading or driving in the car” [12] 
 
“Many patients had tried a range of alternatives to prescribed drugs for sleep 
problems for considerable periods before consulting. These included 
exercise, relaxation, over-the-counter drugs, herbal and miscellaneous 
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remedies, or complementary therapies. Some had even read about cognitive 
behavioural therapy” [17]  
 
“‘…try this tape, calming tapes and all this crap, that I have already tried 
anyway, also herbal stuff. Tried all the herbal stuff, you know in chemists’” 
[19] 
 
The perceived ineffectiveness of these strategies in relation to insomnia could trigger 
a consultation with a GP [17].  
 
3.3.3 Triggers to medical help-seeking 
Medical help-seeking was often triggered by the perceived ineffectiveness of self-
help strategies, or (in the case of insomnia), the perceived severity of the condition. 
Medical consultations were also triggered by significant life events, and pressure 
from others: 
 
“Consultation was often triggered by significant life events or pressure from 
family and friends (social networks). By the time patients consulted with a GP 
or nurse prescriber, they had begun to see their problem as needing medical 
treatment rather than part of the range of normal human experience” [17] 
 
‘Life events’ were also listed as a reason why people started using BZDs [19]. 
 
3.3.4 Attitudes towards treatment options and service provision 
Eight studies included data on what patients wanted/expected when they sought help 
from a healthcare professional, both in relation to the specific type(s) of treatment 
offered, and other aspects of service delivery.  
 
In terms of the specific type(s) of treatment offered, some patients were disappointed 
when a GP suggested treatments that they had already tried: 
 
“‘…we’d tried [a sleep aid like] Nytol, the milky drinks at night, going to bed at 
a certain time and getting up at a certain time all that sort of thing, that’s about 
all they discussed, and we’d already tried those’” [17]  
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Some patients hoped or expected to receive medication for their problem when they 
consulted a healthcare professional, whilst others preferred not to use medication 
due to fear of side-effects: 
 
“Some patients welcomed a prescription they could use as needed. They 
found it empowering that a practitioner trusted them to take hypnotics 
appropriately. Others used the system to gain drugs as a fall-back for the 
future” [17]  
 
“Others emphasised that they had not wanted sleeping tablets. Many patients 
preferred not to resort to hypnotic drugs because of fear of side-
effects…Some found drugs unhelpful or counterproductive” [17]  
 
“When asked about their potential interest in behavioural sleep treatment, one 
participant stated: “I’d eat a bucket of nails if you told me it would help me 
sleep.” This was greeted with a resounding chorus of “me too.” The majority 
of the group agreed that they would like to learn more about sleep and 
insomnia and behavioural strategies to address it” [12]  
 
In terms of other aspects of service delivery, patients discussed a desire for 
continuity of care, more discussion with a health professional prior to receiving a 
prescription, and longer consultation times. Patients wanted more detailed 
information, and for their problem to be taken seriously: 
 
“Pharmacists were seen as either not providing any information on the 
medications or inadequate information” [19]  
 
“There was a general consensus that to get detailed information from their 
GPs, they had to ask ‘lots of questions’, and to ‘probe’ to extract information. 
There was some dissatisfaction with the quality of consultations with GPs, 
and it was said that the short length of a consultation was a barrier to 
receiving a quality service. The issue of time was also raised when talking 
about alternative methods, but they ‘would like to learn and receive 
information on them, as well as more information on the side-effects of the 
drugs they were already taking’” [16]  
 
 12 
“Patients valued clinicians’ empathy, listening, time given, and offer of 
explanations for treatment options…Continuity of care, a flexibility of 
approach, and a consistent or common approach within a practice were also 
found helpful” [17] 
 
However, not all patients desired additional information/discussion: 
 
“…the conflict between the need for medication and the negative 
connotations attached to taking BZDs might explain the absence of a stated 
need for information. If patients had received more information on their 
medications, they might have had to give more thought to taking the 
prescription” [13]  
 
Patients’ knowledge of, and attitudes towards, potential side-effects from medication 
could influence their patterns of use. In some cases, learning that a proposed 
medication was addictive meant that patients preferred alternative treatments. In 
others, patients saw this as less important, or were willing to pay this price for an 
improvement in the quality of their sleep: 
 
“‘When he said that the tablets were addictive I didn’t want to take the tablets. 
So I went another avenue, I went to the hypnotist’” [17]  
 
“‘’My doctor took a lot of persuading to put me back on them [temazepam]. I 
said, “look at my age…what the hell does it matter I’ve been addicted for 20 
years I might die tomorrow”…so, he let me have them’” [17]  
 
The extent to which patients viewed becoming addicted to medication as a problem, 
and whether or not patients were willing to try alternatives influenced their likelihood 
of withdrawal as shown under ‘withdrawal’ below.  
 
Finally, discussion of what patients wanted from services also included the idea of 
establishing specialised withdrawal services: 
 
“Some service users wanted a specialized benzodiazepine service: They 
should maybe have a place where they just…deal in benzos and nothing 
else…like the same as a methadone place” [18] 
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3.3.5 Varying patterns of use 
Descriptions of patterns of medication use were included in most of the papers. With 
the exception of one paper [15] where the majority of patients were reported to be 
taking their medication as prescribed, they encompassed a continuum from patients 
who tried to minimise their usage either through taking a smaller dose than 
prescribed or by taking them only as needed, through to patients who took more than 
they were prescribed:  
“Many said, ‘they do not like to take sleeping tablets, and so only used them 
when needed’” [16]  
 
“Respondents said they used only small doses, they consumed less 
medication than prescribed, and they took it only when necessary” [13] 
 
 
“‘…he said one spoonful and 2 hours later I took another and another. The 
next night I drank two-thirds of the bottle’” [17]  
 
Patients’ own awareness and fear of the dangers of addiction to BZDs contributed to 
a desire to take only the minimum dosage of BZDs by some patients:  
 
“Perceiving that an increase in one’s prescribed benzodiazepine dose would 
result in addiction kept informant’s benzodiazepine use at regular, low doses.  
Evie: I’m afraid to take more than they tell me to of that kind of medicine 
(benzodiazepines)… because I would like to not be taking things that are 
addictive” [14] 
 
3.3.6 Withdrawal 
Several papers (particularly [14, 15, 19]) contained information on withdrawal 
strategies and enablers and barriers to withdrawal. Strategies for withdrawal included 
taking an individually tailored approach and focussing on alternative strategies for 
coping: 
 
“Changes in cognition were the most prevalent strategy….individually tailored 
dose reduction schedules were reported as useful….continuing a non-using 
lifestyle was assisted by being involved in a range of activities such as 
yoga…” [19] 
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Reasons for withdrawal included a realisation that their use of the drugs was 
interfering with their life and the people around them: 
 
“Participants typically said they ceased use when they became unhappy with 
their current lifestyle; realised their use of the drug was self-destructive” [19] 
 
Numerous barriers to withdrawal were discussed in the papers. These included a 
perception from patients of being unable to reduce medication use and fear of what 
would happen if they did discontinue – either based on imagined negative 
consequences or past experiences. Psychological rather than physical dependence 
was the predominant concern: 
 
“‘I really, I don’t really think I can handle things without my meds. I mean I’m 
just really, really, really dependent on them at this point. All of them’” [14] 
 
“‘I just can’t do it. Are you trying to tell me that I should stop or not take it? I’d 
be miserable. Are you gonna tell him [the physician] not to prescribe it 
anymore? Please don’t tell him not to give it to me’” [15] 
 
“With minimal probing, patients’ seeming willingness to consider tapering or 
substitution of alternative medications shifted to an admission that this would 
be an unacceptable option. Patients’ responses ranged from the more simply 
expressed reluctance, “I need it” or “I don’t want to change,” to more 
sophisticated explanations, i.e., anticipation that the taper process would be 
negative” [15] 
 
Links between feelings and beliefs about dependence on medication and the ongoing 
use of medication were seen in two papers:  
 
“Self-reported benzodiazepine dependence was associated with perceptions 
of being unable to reduce benzodiazepine use or a desire to discontinue use 
as well as feeling reliant on benzodiazepines to be comfortable and able to 
handle life.” [14] 
 
“‘…too many other competing demands to address the benzodiazepine: I 
always have like some other issue other than, you know, that one pill’” [15]  
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In addition to barriers internal to the patient, barriers that were external to the patient 
were also discussed, such as lack of support from GPs, a need for specialist 
withdrawal services, and absence of an appropriate support network:  
 
“‘I wasn’t making contact with anyone who could give me some clues on how 
to deal with benzos. For me the lack of contact with people who had done it. I 
went to [Narcotic Anonymous] and.at one time I was going to Al-Anon as well, 
but I wasn’t making contact with anybody who could give me some clues on 
how to deal with benzos’” [19]  
 
3.3.7 Reasons for initial or ongoing use  
Reasons given for the initial use of medication included patient circumstances, life 
events, specific health conditions such as sleep problems, anxiety or pain; the 
perception that medication was effective; and the fact that the medication was 
prescribed by a GP. Anxiety around living alone could also be an important trigger for 
medication use, and a reason for ongoing use [9].  
 
Many patients reported a lack of knowledge or concern about the long term use of 
medication: 
 
“Patients viewed chronic stable benzodiazepine use as responsive to a need 
and as a great benefit. In doing so, they minimized, or even denied, physical 
addictive properties or potential for misuse or inappropriate use” [15] 
 
Reasons for ongoing use included patients feeling that they could live their lives more 
normally whilst using medication: 
 
“For the most part, patients saw benzodiazepines not as a life-enhancing 
luxury but as restorative and necessary to maintain a normal life, and 
anticipated that life without benzodiazepines would be of a decidedly lower 
quality” [15] 
 
“Typically, participants found that benzodiazepines alleviated negative 
feelings enabling them to cope more effectively with stressful situations; 
control panic and anxiety symptoms; allowed them to relax; or reduced 
feelings of aggression…In addition, they felt better and more confident and 
coped with day-to-day adverse events” [19]  
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A passive feeling of trust in GPs was also described, such that patients expected that 
their GP would initiate a change in their BZD use if it were needed: 
 
“Patients said that the relationship with their physicians was based on trust, 
thereby explaining why they did not need more information. They said they 
presumed the doctor would always act in their best interest: ‘I think it is like 
when you go to a caterer, we don’t ask him how he has made the food’” [13] 
 
 
4 Discussion 
This paper synthesised the findings of qualitative research into patients’ experiences 
and perceptions of receiving BZDs and z-drugs and produced a model of patients’ 
experiences and perceptions based on the patient journey. Whilst variation across 
the studies in terms of their participants produced some subtle differences in findings 
(for example heart failure patients cited pacemakers as a cause of insomnia), we 
were still able to identify a number of common themes.  
 
4.1 Strengths and Limitations 
This is the first meta-synthesis of literature on patients’ experiences and perceptions 
of BZD and z-drug prescribing. The studies identified through the systematic review 
were conducted in a range of settings between 2003 and 2014. The studies mainly 
included older adults that were frequent users of BZDs for insomnia, but there was 
some variation between studies in how the populations were selected and the 
primary focus of the paper. For example, one study was based on the perceptions of 
patients with heart failure [12], whereas another focused on experiences of isolation 
and loneliness in older BZD users [9]. There is a risk that the particularities of the 
individual studies are lost in a meta-synthesis. To prevent this we have provided 
descriptions of each study in Table 2.  
 
As with all thematic syntheses, we offer our interpretation of findings and attempt to 
‘go beyond’ the literature to answer a particular question. We have employed a 
number of techniques to enhance the validity of our findings. The analysis was 
undertaken by reviewers from different backgrounds and discussed with a wider 
multi-disciplinary team to consider any bias that may have been introduced. We also 
included direct quotations from the papers to enable critical appraisal of our 
interpretations and to show the range of studies that contributed to each theme. 
 17 
 
4.2 Comparison with the Wider Literature 
Numerous factors influence how we monitor, interpret and respond to bodily 
indicators (‘illness behaviour’) [20]. Previous research shows that many people with 
insomnia or anxiety disorders do not seek medical help for their disorder, and often 
people seek advice from informal helpers or try self-help treatments prior to seeking 
medical help [21-24]. Our findings echo and add to such previous research on the 
determinants of help-seeking, in particular in relation to insomnia. Data from our 
included studies showed that help-seeking for insomnia is triggered by patients 
viewing the negative functional impact of insomnia as ‘severe enough’ to justify 
medical intervention, the perceived ineffectiveness of those self-help strategies that 
were used, significant life events and pressure from others. 
 
Our findings show that several factors perpetuated the use of BZDs and z-drugs. 
Firstly psychological dependence – the ‘withdrawal’ and ‘reasons for initial or ongoing 
use’ themes showed that patients viewed their medication as effective and expressed 
fear that tapering use would have negative consequences, and that withdrawal would 
leave them unable to cope. Secondly, absence of support – the ‘attitudes towards 
treatment options and service provision’ and ‘withdrawal’ themes showed that some 
patients were dissatisfied with GP consultations and there were a number of things 
that could be done to improve service provision. There was a perceived lack of 
support from GPs to discontinue use, and the ‘reasons for initial or ongoing use’ 
theme indicated that patients trusted their GP to recommend withdrawal if it was the 
best option for them, and GPs had not done this. Some patients expressed a desire 
for a specialised support network or service for withdrawal from BZDs. Finally, the 
‘reasons for initial or ongoing use’ theme showed that patients reportedly denied, or 
stated that they were unaware of the side-effects of medication.  
 
These findings resonate with work on patient barriers and enablers for deprescribing 
[25] which, amongst other things, identified the extent of a patient’s agreement with 
the ‘appropriateness’ of cessation, fear of cessation and the presence or absence of 
a process for cessation as key themes. 
 
4.3 Implications for Future Practice and Research 
Exploring this literature has enabled us to identify points throughout the patient 
journey where strategies could be introduced to support both healthcare 
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professionals1 and patients to reduce misuse of BZDs and z-drugs, and find effective 
alternative ways to manage their health condition(s). These are summarised in Table 
2. 
 
[Table 2 Strategies for improving patient experience of insomnia management and 
reducing misuse of benzodiazepines and z-drugs here] 
 
Through considering the implications of our analytical themes and the wider literature 
around strategies for reducing inappropriate use of BZDs and z-drugs and supporting 
patients with conditions for which these drugs may be prescribed, we identified three 
main strategies which may support safer prescribing.  
 
Firstly, creation of educational resources could be helpful. Direct patient education 
has previously been shown to be effective in encouraging patients to discuss 
discontinuing BZD use with physicians or pharmacists and achieving desistance or 
dose reduction when compared to usual care [26]. Our study showed that patients 
perceived their own self-help strategies to be ineffective prior to consulting a 
healthcare professional and that, in some cases, patients denied or were unaware of 
the side-effects of BZDs/z-drugs. Educational resources could detail what guidelines 
recommend in terms of support for insomnia, anxiety or pain, outlining appropriate 
self-care strategies and how to implement them, helping patients to have realistic 
expectations of what treatments might achieve e.g. what ‘normal’ or ‘good quality’ 
sleep is, and directing patients towards alternative treatments such as (online) 
cognitive-behavioural therapy (CBT). These resources should also detail the potential 
side-effects of using BZDs and z-drugs, and stress that they are only recommended 
for short-term use followed by staged withdrawal at a pre-determined time. 
Appropriate dissemination of such resources (online, and via healthcare 
professionals such as GPs, practice nurses and community pharmacists) would raise 
both patients’ and healthcare professionals’ awareness of alternatives to medication 
and the risks of prescribing or taking medication, particularly for older adults, thus 
modifying demand for pharmacological interventions both prior to and at the point of 
access. Resources could include a sleep diary that could be used to develop tailored 
provision of alternative treatments and/or stepped withdrawal. 
 
                                                 
1 By ‘healthcare professionals’, we mean a wide variety of roles including GPs, psychiatrists, 
psychologists, practice nurses, community pharmacists and other allied health professionals 
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Secondly, as suggested in our previous research [8], alternatives such as CBT that 
have been shown to be effective and are recommended in clinical guidelines need to 
be made more widely available. One reason for medical help-seeking is that patients 
perceive the negative impact of a condition to be serious enough to warrant medical 
intervention. CBT techniques can be used to identify and reframe negative views 
about health conditions (referred to as ‘cognitive restructuring’, ‘cognitive reframing’ 
or ‘positive reframing’) [27]. Research in pain management has found that a patient 
accepting their condition can itself lead to positive outcomes [28], and (computerised) 
CBT has been shown to be effective for patients with anxiety disorders and for 
patients with insomnia [29-31]. Alongside directing ‘new’ patients to alternatives, 
further research is needed to ascertain the efficacy of different approach(es) to 
deprescribing (e.g. patient education, group therapy, mixed interventions). Here, 
consideration needs to be given to the influence of patient characteristics (including 
things like comorbidities) on this [32]. Findings of such research should be shared 
with a wide range of healthcare professionals. 
 
Thirdly, this study suggests extending the healthcare professional-patient dialogue in 
a targeted way at the point of help-seeking to explore and encourage the use of non-
pharmacological treatments, clarify issues around self-help strategies and how best 
to implement them, encourage open and honest dialogue, and ensure that patients 
know that sleep problems are taken seriously. Adherence to self-help treatments is 
an important consideration, with previous research showing this to be at 
approximately 50% for technology mediated insomnia treatments (i.e. those delivered 
via technology rather than face-to-face) [33]. Part of the ongoing dialogue between 
the healthcare professional and patient may be to try to maintain a higher level of 
adherence to ensure maximum effectiveness of non-pharmacological treatments. 
 
As set out in NICE guidelines [1-3], pharmacological interventions should be a last 
resort. Previous work shows that GPs sometimes assume that patients want 
medication or would be resistant to the idea of withdrawing from medication [8, 34]. 
GPs and other healthcare professionals should be made aware of the potential 
influence of perceived patient expectations on prescribing and should be encouraged 
to directly discuss patients’ preferences with them. As the literature reviewed here 
shows, patients’ patterns of use and likelihood of withdrawal are influenced by their 
understanding of and attitude towards the risk of addiction. Not all patients want 
medication, and whilst some patients are not concerned about the risk of addiction, 
others would prefer to try alternative treatments to avoid this risk.  
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At follow-up appointments various healthcare professionals, including community 
pharmacists can focus on medication management,  ascertain patients’ patterns of 
medication use (rather than assuming that they use it as directed), discuss the need 
for staged withdrawal, and discuss issues around psychological dependence and any 
changes in patients’ circumstances.  
 
GPs and patients both identify short consultation times as a problem, and work 
pressures may pose a barrier to extending the GP-patient dialogue. However, 
personalised support can be delivered by a range of healthcare professionals 
including community pharmacists, and in the long-term, this may save time as 
patients will not be returning for repeat prescriptions. The potential benefits of this 
could be the subject of future research.   
 
Differences in perspectives from healthcare professional and patient of the problem 
and its solution are important when considering how to reduce inappropriate 
prescribing. Some of these differences come to light when comparing the results of 
this meta-synthesis of patient perspectives to our earlier meta-synthesis on GP 
perspectives [8]. GPs expressed concerns that there were a lack of alternatives to 
medication, and when these were available they were time-consuming and difficult to 
access [8], whereas in this meta-synthesis we identified that patients felt they had 
tried alternatives to medication before seeing their GP, but that these were 
ineffective. However, the alternatives tried were not necessarily those that would be 
recommended by a healthcare professional. Establishing a shared concept between 
patient and GP of the value of alternatives to medication and likelihood of success 
could help patients to then re-explore these avenues under the guidance of their GP, 
leading to greater success in their use. 
 
5. Conclusion 
Benzodiazepines and z-drugs are often inappropriately prescribed long-term for the 
treatment of insomnia, pain and anxiety disorders, particularly in older people. 
Inappropriate use is perpetuated by patients’ psychological dependence on these 
drugs, an absence of support to discontinue use, and patients’ lack of awareness of, 
or denial of, the side-effects of these medications. Safer prescribing could be 
achieved through the creation of educational resources, increased availability and 
use of effective alternatives recommended in clinical guidelines like CBT, and an 
extended GP-patient dialogue. 
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Table 1 Description of Studies Included in the Review 
Study Aims Sample Method of Data 
Collection 
Method of Data Analysis Theoretical 
Perspective 
Andrews 
et al., 
(2013), 
(USA) 
[12] 
To evaluate the 
perceptions of patients 
with heart failure about “1) 
insomnia and its 
consequences; 2) 
predisposing, 
precipitating,  and 
perpetuating factors for 
insomnia; 3) self-
management strategies 
and treatments for 
insomnia; and 4) 
preferences for insomnia 
treatment” 
A purposive sample of 6 men and 5 
women from one outpatient heart 
failure programme 
 
Ages: 50-91 years  
 
All had New York Heart Association 
class II or III heart failure and a 
variety of comorbid conditions  
 
All were taking medication for 
insomnia 
A mixed-methods study 
combining self-
completed 
questionnaires and two 
focus groups 
 
The focus groups used 
a semi-structured 
interview guide based 
on Spielman’s 3 P 
Model of insomnia  
 
Also kept notes of 
participants’ responses, 
body language and 
group processes 
 
Four participants 
attended a second focus 
group to review and 
The recordings of the focus 
groups were transcribed 
and content analysis was 
conducted in Atlas.ti   
“The PI and PhD student 
conducted initial coding to 
organize the narrative data 
into mutually exclusive 
categories and then 
clustered the resulting 
codes to identify central 
themes”. Results were then 
reviewed by two further 
investigators reviewed the 
results and confirmed the 
clustered results 
Unclear 
 26 
verify findings 
Anthiere
ns et al., 
(2007), 
Belgium 
[13] 
“To explore patients’ 
views and expectations 
regarding their first 
prescription for 
benzodiazepines” 
15 family practice patients (13 
female, 2 male)  
 
Ages: 18-76 years 
 
All had received prescriptions of 
BZDs for the first time 
 
Patients were recruited from general 
practices in the regions of Ghent and 
Brussels. Both daily and intermittent 
users were included 
Semi-structured 
interviews  
 
Interviews were based 
on open ended 
questions with 
participants at home 
Interviews were transcribed 
verbatim. “Data were 
analysed using the 
principles of thematic 
analysis and incorporating 
the data-driven inductive 
approach”. Two 
researchers used the 
constant comparative 
method to identify emerging 
themes then categories for 
analysis. A third researcher 
was used to improve 
consistency and reliability 
of the analyses. Field notes 
were also used 
Phenomenol
gical 
Canham, 
S.L. et 
al., 
(2014), 
USA [14] 
To "investigate the 
subjective experiences 
and meanings of 
benzodiazepine 
dependence in a sample 
of women age 65 and 
English-speaking White-European 
women  
 
Ages: 65-89 years  
 
Self-identified as using a 
Multiple-visit semi-
structured interviews 
 
All interviews were 
conducted by the first 
author  
Interviews were transcribed 
verbatim and analysed in 
Atlas.ti. Transcripts were 
iteratively coded into 
themes by two researchers 
working independently. 
Phenomenol
ogical 
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older who self-identified 
as chronic 
benzodiazepine users. 
Our focus was on whether 
women who are chronic 
benzodiazepine users 
identified themselves as 
dependent, how users 
perceived dependence to 
benzodiazepines, and 
how meanings and 
understandings shaped 
individual experiences of 
benzodiazepine use" 
benzodiazepine on a near daily or 
daily basis in at least the 3 months 
prior to data collection for a sleep or 
anxiety problem 
 
15 people participated, and 12 of 
these specifically discussed their 
perceptions of benzodiazepine 
dependence 
 
The paper also provides details 
about marital status and living 
arrangements, self-identified 
dependence on benzodiazepines and 
length of usage 
 
Kept a "detailed 
notebook of memos, 
observations, and 
impressions" 
Coded data were then 
discussed to reach 
consensus 
Canham 
S.L. 
(2015), 
USA [9] 
To examine data from a 
larger study of 
experiences and 
perceptions of 
benzodiazepine use for 
descriptions of loneliness 
and social isolation in 
older women. The 
analysis presented here 
7 White European  women  
 
Ages: 65-86 years  
 
All participated in the parent study 
and had used benzodiazepines at 
least five days a week for at least the 
previous three months and shared 
experiences of social isolation and 
Semi-structured 
multiple-visit interviews  
 
Interviews were based 
on open ended 
questions, some of 
which were developed in 
prior research. 
Conducted in 
The transcripts were 
entered into Atlas.ti and 
iteratively coded by two 
independent qualitative 
data experts. Data were 
discussed in-depth to 
resolve any discrepancies. 
The analysis conducted 
here relates to the theme 
Phenomenol
ogical  
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asked “what is the 
subjective experience of 
loneliness and social 
isolation for older women 
who regularly use a 
benzodiazepine for a 
sleep or anxiety 
problem?” 
loneliness  
 
“Participants were recruited through 
newspaper advertisements and flyers 
distributed in independent and 
assisted living senior residences in a 
large metropolitan area” in the USA 
 
The paper also provides details of 
marital status, specific medication 
used and length of usage 
participants’ homes or 
private meeting rooms 
 
Also used fieldnotes 
and sub-themes around 
social isolation and 
loneliness  
Cook et 
al., 
(2007), 
USA [15] 
“To understand patient 
factors contributing to the 
chronicity of 
benzodiazepine use by 
older adults as a first step 
in the development of 
acceptable intervention 
strategies for 
taper/discontinuation or 
prevention of chronic use” 
from the perspective of 
older patients 
50 regular anxiolytic benzodiazepine 
users, 85% female  
 
Ages: 61-95 years 
 
Recruited through 33 primary care 
physicians from the Philadelphia 
Pennsylvania area.  
 
81% Caucasians and 19% African-
Americans  
 
Also provides details of marital 
Semi-structured 
telephone interviews  
 
Based upon reviews of 
the literature and pilot 
interviews 
Interviews where 
audiotaped and 
professionally transcribed. 
The study used thematic 
content analysis in NVivo. 
Investigators met as a 
group to “abstract and 
condense themes, identify 
common themes and 
reconcile conflicting 
observations” 
Unclear 
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status, employment status, specific 
drug types, dosage and frequency, 
and reason for prescription 
Dollman 
et al., 
(2003), 
Australia 
[16] 
“To identify strategies 
needed to increase use of 
non-drug interventions in 
the management of 
insomnia in the elderly” 
16 focus group participants  
 
Recruited for focus groups through 
an advertisement placed on a notice 
board in a local government 
community centre 
  
209 GPs completed questionnaires 
 
The paper details their sex, and 
various details about their practice 
and patient population 
A self-administered 
questionnaire and 3 
focus groups 
 
The questionnaire was 
sent to all 425 GPs in 
the Southern Division of 
General Practice and 
included open-ended 
questions  
 
Focus groups were held 
for older people to clarify 
enabling factors that 
may assist GPs and 
consumers in 
encouraging non-drug 
alternatives 
For the focus groups a 
member of the research 
team took notes and 
discussions were tape 
recorded, transcribed and 
analysed using thematic 
analysis  
Unclear 
Dyas et 
al., 
"To explore patients' and 
primary care practitioners' 
30 patients participated, split across 
11 focus groups. 11 male and 19 
Focus groups and field 
notes 
"Interview data were 
managed using 
Phenomenol
ogical 
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(2010), 
(UK) [17] 
expectations, 
experiences, and 
outcomes of consultations 
for sleep difficulties, as a 
basis for improving the 
treatment of insomnia in 
primary care"  
female 
 
Ages: 25 -70 years 
 
Participants had consulted with 
insomnia during the previous 6 
months and were “selected from 
eight general practices taking part in 
a quality improvement collaborative”  
 
Recruitment was via postal invitation, 
waiting room posters, and newspaper 
advertisements 
 
The sample was selected to ensure 
“that participants were of different 
sex, age, work, and socioeconomic 
status". The paper provides data on 
these characteristics, the duration of 
their sleep problems, and the 
remedies tried  
 
"Separate focus groups 
for practitioners and 
patients"  
"Semi-structured 
scripted question 
schedules were 
used…Field notes were 
made and group 
proceedings were tape-
recorded and 
transcribed verbatim” 
MAXQDA2007. Constant 
comparative analysis was 
used, employing a coding 
template agreed by three 
authors for the subsequent 
transcript analysis. A priori 
themes implicit in the focus 
group schedule were not 
used in the template” 
Kapadia 
et al., 
(2007), 
"To conduct a survey of 
healthcare workers and 
high-dose 
The focus group that included 
patients “consisted of community 
drug workers (n=3) and high-dose 
Focus groups 
 
"Both focus groups were 
The audiotapes were 
transcribed verbatim and 
analysed using thematic 
Unclear 
 31 
UK [18] benzodiazepine-
dependent users to gauge 
opinion on improving 
services for this client 
group". Focus groups 
were conducted to inform 
the questionnaire 
development 
benzodiazepine-dependent clients 
(n=9) who accessed their services 
 
Recruitment was achieved by 
contacting all five community drug 
services covering one inner-London 
borough.”  
 
Clients were recruited by the 
community drugs workers 
facilitated by an 
independent non-clinical 
researcher and 
audiotaped. Two further 
researchers took notes 
to track turn-taking so 
that each individual's 
speech could be 
identified on the 
audiotape” 
analysis in NVivo   
Parr et 
al., 
(2006), 
Australia 
[19] 
To gain a more detailed 
understanding of 
perceptions by GPs and 
benzodiazepine users of 
starting, continuing and 
stopping benzodiazepine 
use 
28 GPs and 23 benzodiazepine 
users from around Cairns, Australia. 
14 female, 9 male 
 
Patients had at some time been 
prescribed daily BZD for 3 months or 
more.  
 
Mean age = 50 years.  
 
The paper also details the reasons 
for the prescription 
Semi-structured 
interviews 
Full transcription (apart 
from 4 interviews). 
Domains and categories 
developed on 3 interviews 
from GP and user, then 
refined and applied to 
remaining data with 
additional auditing 
Unclear, but 
cites 
‘Consensual 
Qualitative 
Research 
approach.  
*BZDs = Benzodiazepines; GP = General Practitioner; PI = Principal Investigator; UK = United Kingdom; USA = United States of America 
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Table 2: Strategies for improving patient experience of insomnia management and reducing misuse of benzodiazepines and z-drugs 
Theme/Point in Patient Journey Strategy for Healthcare Professionals Strategy for Patients 
1. Patients’ negative 
perceptions of insomnia (or 
anxiety or pain) and its 
impact 
Direct patients towards (online) Cognitive Behavioural Therapy 
(CBT) and/or educational resources to change their attitude (for 
example, ensuring realistic expectations of ‘normal’ sleep) and 
support cognitive reframing of its impact 
Attend CBT and/or access educational resources 
2. Failed self-care strategies  Discuss the coping strategies that a patient has tried prior to 
consulting. Establish whether or not these are ‘recommended’ 
coping strategies and/or have been implemented well. Suggest 
next steps accordingly 
Discuss coping strategies tried to date with the 
healthcare professional. Try any non-pharmacological 
strategies recommended by the healthcare 
professional that have not been tried already/modify 
how these are implemented 
3. Triggers to medical help-
seeking 
Follow steps set out in educational resources – discussing non-
pharmacological forms of treatment first as recommended by 
National Institute for Health and Care Excellence (NICE) 
guidelines 
Access online information re: what steps healthcare 
professionals should follow to support patients 
4. Attitudes towards treatment 
options and service provision 
Modify demand for pharmacological treatments at the point of 
access. Direct patients towards educational resources and raise 
awareness of side-effects and that benzodiazepines (BZDs) and 
z-drugs should only be taken in the short-term followed by 
staged withdrawal at a pre-determined time 
Access educational resources recommended by the 
healthcare professional 
5. Varying patterns of use of 
medication 
Ask patients how they use their BZDs/z-drugs – do not assume 
that they use them as directed 
Discuss patterns of use honestly with the healthcare 
professional 
6. Withdrawal Discuss the need for staged withdrawal with patients Create a plan for staged withdrawal with the 
 33 
healthcare professional 
7. Reasons for initial or ongoing 
use  
Discuss psychological dependence with patients and establish 
whether the circumstances that led to an initial prescription have 
changed 
Reflect on circumstances which led to beginning 
BZDs and consider whether any life stressors have 
changed since this time 
 34 
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Supplementary Table 1 MEDLINE search strategy  
Line 
Number 
Search Term* 
1 AB qualitative 
2 AB interview* 
3 AB focus group* 
4 AB theme* 
5 AB experience* 
6 MH Qualitative Research 
7 MH Interviews as Topic+ 
8 AB attitude* 
9 AB perception* 
10 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 
11 MH Benzodiazepines+ 
12 AB benzodiazepine* 
13 MH Anti-Anxiety Agents 
14 MH Hypnotics and Sedatives 
15 AB z-drug* 
16 AB z drug* 
17 AB BZD 
18 AB anti-anxiety agent* 
19 AB anti anxiety agent* 
20 AB antianxiety agent* 
21 AB non-benzodiazepine* 
22 AB nonbenzodiazepine* 
23 AB non benzodiazepine* 
24 AB temazepam 
25 AB nitrazepam 
26 AB lormetazepam 
27 AB zopiclone 
28 AB zaleplon 
29 AB zolpidem 
30 AB eszopiclone 
31 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR 
S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR 
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S29 OR S30 
32 MH Patients 
33 AB patient* 
34 AB patient experience* 
35 AB patient attitude* 
36 AB patient perception* 
37 AB service user* 
38 AB service user experience* 
39 AB service user attitude* 
40 S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 
41 S10 AND S31 AND S40 
42 S10 AND S31 AND S40 + Limiters: 2000-2014 
*Here, ‘*’ indicates a wildcard search for any words which begin with the letters that 
precede the asterisk, and ‘+’ indicates that the search term has been ‘exploded’ to 
include all references indexed to that term and narrower terms beneath it 
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Supplementary Table 2: Quality Appraisal of Papers 
Paper Clear 
Statement 
of Research 
Aims? 
Is a 
Qualitative 
Methodology 
Appropriate? 
Design Sampling Data 
Collection 
Reflexivity Ethics Analysis Findings Value Overall 
CASP 
Rating 
Andrews et al., 
(2013) [12] 
1 1 1 0 1 0 1 1 1 1 8 
Anthierens et 
al., (2007) [13] 
1 1 1 1 1 0 1 1 1 1 9 
Canham, S.L. 
et al., (2014) 
[14] 
1 1 1 1 1 0 1 1 1 1 9 
Canham S.L. 
(2015) [9] 
1 1 1 0 1 1 1 1 1 1 9 
Cook et al., 
(2007) [15] 
1 1 1 1 1 0 1 1 1 1 9 
Dollman et al., 
(2003) [16] 
1 1 1 1 1 0 0 1 1 1 8 
Dyas et al., 
(2010) [17] 
1 1 1 1 1 0 1 1 1 1 9 
Kapadia et al., 
(2007) [18] 
1 1 1 1 1 0 1 1 1 1 9 
Parr et al., 
(2006) [19] 
1 1 1 1 1 1 1 1 1 1 10 
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Supplementary Table 3: Creation of Themes Using Thematic Synthesis* 
Initial Themes Descriptive Themes Analytical Themes 
 Lack of concern or knowledge of side-effects 
 Justifying initiation or help-seeking to GP 
 Reasons for ongoing use 
 Patterns of use - influences 
 Attitudes towards the drugs 
 Reasons for starting use other than insomnia 
 Patterns of use – patient vs GP led  
 Patterns of use - justifications 
 Reasons for use 
 
 Attitudes towards treatment options and service 
provision 
 Reasons for initial or ongoing use 
 Triggers to medical help-seeking 
 Varying patterns of use 
 Pre-GP coping strategies 
 Ways of coping 
 Coping with insomnia 
 
 Failed self-care strategies 
 Desired alternatives 
 Attitudes to alternatives 
 Alternatives to BZDs  Failed self-care strategies  
 Attitudes towards treatment options and service 
provision 
 Withdrawal 
 Patterns of use 
 Patterns of use – self-minimising 
 How people take 
them/patterns of use 
 Varying patterns of use 
 Provision of information from services 
 Views on GP services/what patients want 
 Withdrawal services 
 Services 
 
 
 Attitudes towards treatment options and service 
provision 
 Reasons for initial or ongoing use 
 Withdrawal services 
 Barriers to withdrawal 
 Reasons for withdrawing 
 Ways of withdrawing and staying clean 
 Withdrawal 
 
 Attitudes towards treatment options and service 
provision  
 Withdrawal 
 Insomnia description – can’t sleep 
 Insomnia description – can’t stay asleep 
 Causes of insomnia 
 Perpetuating factors for insomnia 
 Insomnia as cause of other health problems 
 Negative impact of insomnia 
 Patients’ perceptions of 
insomnia 
 
 Patients’ negative perceptions of insomnia and 
its impact 
 
*Data were initially coded line-by-line into 26 themes based on the meaning of each line. We then discussed the overlap and relationships between these 
themes, and grouped them into higher-level descriptive themes to encapsulate the meaning of groups of the initial themes. Following this, we considered the 
 40 
data within each of the descriptive themes in relation to the research question. Through specifically considering what the data tell us about why patients begin 
and continue to use BZDs and z-drugs, and potential strategies for supporting withdrawal and encouraging safer prescribing, we created the final analytical 
themes and organised them into a model. Note that it was possible for the lower-level themes to fit into more than one higher-level theme.  
 
 
